A PHASE Ⅲ RANDOMIZED STUDY OF MITOMYCIN/VINDESINE/CISPLATIN VERSUS IRINOTECAN/CARBOPLATIN VERSUS PACLITAXEL/CARBOPLATIN WITH CONCURRENT THORACIC RADIOTHERAPY FOR UNRESECTABLE STAGE Ⅲ NON-SMALL-CELL LUNG CANCER: